Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pediatric Drugs is Scopus-indexed (Q1, CiteScore 7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Adis.
Checked against the index lists dated .
ISSN 1174-5878Verify ISSN ↗1179-2019Verify ISSN ↗
Publisher: Adis
Cost to publish: About US$4,990 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pediatrics, Perinatology and Child Health | 25 / 351 | 93rd | Q1 |
| Pharmacology (medical) | 56 / 278 | 80th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q1, CiteScore 7.
Pediatric Drugs is Q1 in Pediatrics, Perinatology and Child Health (rank 25 of 351) and Q1 in Pharmacology (medical) (rank 56 of 278), by CiteScore 2025.
Pediatric Drugs is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7, which places it in quartile Q1 at the 93rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.224, quartile Q1, with an H-index of 77.
The publisher lists an article processing charge of about US$4,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pediatric Drugs is published by Adis. Its print ISSN is 1174-5878 and its online ISSN is 1179-2019.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pediatric Drugs has an h-index of 87 and a 2-year mean of 4.37 citations per paper (OpenAlex). Its Scopus CiteScore is 7, quartile Q1. On 2-year citations it ranks #11 of 344 Scopus journals in Pediatrics, Perinatology and Child Health.
Pediatric Drugs published 59 papers in 2025; its busiest recent year was 2017 with 70. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from United States (26.9%), New Zealand (12.4%) and Italy (8.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.